423 related articles for article (PubMed ID: 33144171)
1. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
Ugbode C; West RJH
Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2B
Waegaert R; Dirrig-Grosch S; Liu H; Boutry M; Luan P; Loeffler JP; René F
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454086
[TBL] [Abstract][Full Text] [Related]
5. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
6. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).
Cox LE; Ferraiuolo L; Goodall EF; Heath PR; Higginbottom A; Mortiboys H; Hollinger HC; Hartley JA; Brockington A; Burness CE; Morrison KE; Wharton SB; Grierson AJ; Ince PG; Kirby J; Shaw PJ
PLoS One; 2010 Mar; 5(3):e9872. PubMed ID: 20352044
[TBL] [Abstract][Full Text] [Related]
7. Retrovirus reactivation in CHMP2BIntron5 models of frontotemporal dementia.
Fort-Aznar L; Ugbode C; Sweeney ST
Hum Mol Genet; 2020 Sep; 29(16):2637-2646. PubMed ID: 32628265
[TBL] [Abstract][Full Text] [Related]
8. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
Talbot K; Ansorge O
Hum Mol Genet; 2006 Oct; 15 Spec No 2():R182-7. PubMed ID: 16987882
[TBL] [Abstract][Full Text] [Related]
10. The role of CHMP2B
Krasniak CS; Ahmad ST
Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
[TBL] [Abstract][Full Text] [Related]
11. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
[TBL] [Abstract][Full Text] [Related]
12. Frontotemporal dementia caused by CHMP2B mutations.
Isaacs AM; Johannsen P; Holm I; Nielsen JE;
Curr Alzheimer Res; 2011 May; 8(3):246-51. PubMed ID: 21222599
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.
Häkkinen S; Chu SA; Lee SE
Neurobiol Dis; 2020 Nov; 145():105063. PubMed ID: 32890771
[TBL] [Abstract][Full Text] [Related]
14. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
15. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
Ji AL; Zhang X; Chen WW; Huang WJ
J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
[TBL] [Abstract][Full Text] [Related]
16. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
[TBL] [Abstract][Full Text] [Related]
17. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
[TBL] [Abstract][Full Text] [Related]
18. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
Kumar V; Islam A; Hassan MI; Ahmad F
Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
[TBL] [Abstract][Full Text] [Related]
19. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
Cui R; Tuo M; Li P; Zhou C
Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants.
De Marchi F; Tondo G; Corrado L; Menegon F; Aprile D; Anselmi M; D'Alfonso S; Comi C; Mazzini L
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
